Norepinephrine adrenergic receptor

Norepinephrine adrenergic receptors are a group of G protein-coupled receptors that mediate the effects of the catecholamine neurotransmitter norepinephrine (noradrenaline) in the sympathetic nervous system[7][9]. These receptors are broadly divided into alpha (α1, α2) and beta (β1, β2, β3) subfamilies, each further subdivided into multiple molecular subtypes[7][9]. The alpha-adrenergic receptors are primarily involved in vasoconstriction and modulation of neurotransmitter release, while beta-adrenergic receptors mediate effects such as increased heart rate, contractility, and bronchodilation[3][6][7]. Norepinephrine adrenergic receptors play major roles in controlling vascular tone, cardiac function, smooth muscle contraction, and several central nervous system processes[1][7][9]. They are important therapeutic targets for drugs treating cardiovascular, psychiatric, and respiratory diseases, but clinical use may be complicated by limited selectivity, off-target effects, and dose-related adverse reactions[2][3][8].

Other names

Adrenergic receptorAdrenoceptorAlpha-adrenergic receptor (α-adrenergic receptor)Beta-adrenergic receptor (β-adrenergic receptor)Norepinephrine receptor

Agonism (direct activation of the receptor); Antagonism (direct receptor blockade); Inverse agonism (stabilization of inactive receptor conformations); Indirect agonism (increased synaptic norepinephrine, e.g., via reuptake inhibition or stimulated release)